Hormosan was founded in Germany over 50 years ago and ever since has developed successfully into a mid-sized pharmaceutical company.

Today we market a large portfolio spanning from innovative medicines to generics and we focus on three core therapeutic areas:

Rare diseases in neurology
Pain therapy for chronic pain and headaches
Sexual health with focus on oral contraceptives, erectile dysfunction and HIV

With our innovative medicines we address so far unmet needs of our patients. Specific formulations or dosage forms of our specialty-like medications enhance patient benefits and compliance. And with our generics we provide high quality therapeutic options with attractive pricing.

2008 Hormosan was acquired by the international pharmaceutical LUPIN Group. Being embedded in this global network also continuously drives our competitiveness which is the fundament for us to provide long-term attractive therapeutic options to patients in the German market.

Therapeutics

Pharmaceutical

Health Care

Hormosan Pharma GmbH

Peer Seeger

Dr. Karl Werner

Daniel Drogan

Jonathan Amtage

Sylvia Heß

Dagmar Partsch

Hormosan Pharma GmbH

Org chart

Teams

Similar companies